南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停

无胰岛素简化培养基系统高效诱导人多能干细胞分化为内皮和平滑肌细胞

Efficient endothelial and smooth muscle cell differentiation from human pluripotent stem cells through a simplified insulin-free culture system

Fengzhi Zhang, Yonglin Zhu, Jing Chen, Wenhua Kuang, Rujin Huang, Fuyu Duan, Yaqian Li, Lin Wang, Hui Qiu, Xia Chen, Jia Ming, Peng Liu, Yanan Du, Sophia Chia-Ning Chang, Ligong Chen, Jie Na

Journal:BIOMATERIALS

IF:12.48

DOI:10.1016/j.biomaterials.2021.120713

PMID:33618219

Published:2021-02-11

research field:肿瘤学分子生物学药理学药物设计与开发药物化学

Abstract

A major obstacle for using human pluripotent stem cells (hPSCs) derived vascular cells for cell therapy is the lack of simple, cost-saving, and scalable methods for cell production. Here we described a simplified and chemically defined medium (AATS) for endothelial cells (ECs) and smooth muscle cells (SMCs) differentiation. AATS medium does not contain insulin, enabling the rapid and highly efficient vascular mesoderm formation through accelerating metabolic and autophagy-enhanced mesoderm induction. Transcriptome profiling confirmed that hPSC-derived ECs and SMCs in the AATS medium closely resembled primary ECs and SMCs formed in vivo . ECs appeared to adhere and grow better in the AATS medium over other cell types, which allowed the purification of CD31 + CD144 + double-positive cells. Furthermore, the AATS medium was compatible with 3D microscaffold (MS) culture, which may facilitate large-scale bioproduction of ECs. HPSC-derived ECs and SMCs in the AATS medium exhibited strong revascularization potential in treating murine ischemic models. Our study provided a cost-effective and efficient medium system to manufacture GMP compatible, off-the-shelf ECs, and SMCs to model human diseases and vascular repair.

本文使用的Yeasen产品

购物车
客服
转染试用